LEGO-LPPO

N/A

Report date: 2025/06/11 10:45:31
NME

Base Information

Drug NameLEGO-LPPO
Drug Alias Namelinker-evolved-group-optimized-lipophosphonoxins (Institute of Organic Chemistry And Biochemistry/ICOB Tech sro)
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionAntimicrobial multidrug resistance inhibitors
TargetsUpdating
Therapy Area/IndicationsMultidrug-Resistant InfectionStaphylococcal InfectionsGram-Positive Bacterial Infections +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInstitute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences
China Registration ClassN/A

Develop Information

Active CompaniesICOB TECHNOLOGY LLCInstitute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences
Inactive CompaniesN/A
Active IndicationsMultidrug-Resistant InfectionStaphylococcal InfectionsGram-Positive Bacterial Infections +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A